Evaluating the safety profile of anti-platelet therapy in patients undergoing elective inguinal hernia repair: a systematic review and meta-analysis

医学 荟萃分析 置信区间 优势比 腹股沟疝 随机对照试验 外科 输血 内科学
作者
Matthew G. Davey,William Joyce
出处
期刊:Irish Journal of Medical Science [Springer Nature]
卷期号:193 (2): 897-902
标识
DOI:10.1007/s11845-023-03480-w
摘要

Abstract Introduction There remains no consensus surrounding the safety of prescribing anti-platelet therapies (APT) prior to elective inguinal hernia repair (IHR). Aims To perform a systematic review and meta-analysis evaluating the safety profile of APT use in patients indicated to undergo elective IHR. Methods A systematic review was performed in accordance with PRISMA guidelines. Meta-analyses were performed using the Mantel–Haenszel method using the Review Manager version 5.4 software. Results Five studies including outcomes in 344 patients were included. Of these, 65.4% had APT discontinued (225/344), and 34.6% had APT continued (119/344). The majority of included patients were male (94.1%, 288/344). When continuing or discontinuing APT, there was no significant difference in overall haemorrhage rates (odds ratio (OR): 1.86, 95% confidence interval (CI): 0.29–11.78, P = 0.130) and in sensitivity analysis using only RCT data (OR: 0.63, 95% CI: 0.03–12.41, P = 0.760). Furthermore, there was no significant difference in reoperation rates (OR: 6.27, 95% CI: 0.72–54.60, P = 0.590); however, a significant difference was observed for readmission rates (OR: 5.67, 95% CI: 1.33–24.12, P = 0.020) when APT was continued or stopped pre-operatively. There was no significant difference in the estimated blood loss, intra-operative time, transfusion of blood products, rates of complications, cerebrovascular accidents, myocardial infarctions, or mortality observed. Conclusion This study illustrates the safety of continuing APT pre-operatively in patients undergoing elective IHR, with similar rates of haemorrhage, reoperation, and readmission observed. Clinical trials with larger patient recruitment will be required to fully establish the safety profile of prescribing APT in the pre-operative setting prior to elective IHR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
桐1210完成签到 ,获得积分20
刚刚
默默的泡芙完成签到,获得积分10
2秒前
sunshine完成签到,获得积分10
3秒前
WenzongLai完成签到,获得积分10
5秒前
冷酷的闹闹完成签到 ,获得积分10
7秒前
研友_8KX15L发布了新的文献求助10
7秒前
李新光完成签到 ,获得积分10
9秒前
小绵羊发布了新的文献求助10
10秒前
阿兹卡班完成签到 ,获得积分10
12秒前
12秒前
13秒前
赵老尕完成签到,获得积分10
13秒前
王敏完成签到 ,获得积分10
14秒前
yt完成签到,获得积分10
14秒前
cctv18应助galioo3000采纳,获得10
15秒前
吴咪完成签到,获得积分10
15秒前
Rqbnicsp完成签到,获得积分10
16秒前
小白狮666发布了新的文献求助10
16秒前
傲娇的凡旋完成签到,获得积分10
17秒前
双黄应助路佳金采纳,获得10
17秒前
小绵羊完成签到,获得积分20
18秒前
zhang完成签到,获得积分10
19秒前
心灵美的安雁完成签到,获得积分10
19秒前
lbx完成签到,获得积分10
20秒前
20秒前
彳亍1117应助小绵羊采纳,获得10
20秒前
小蘑菇应助小绵羊采纳,获得10
20秒前
星空完成签到,获得积分10
21秒前
22秒前
吉势甘完成签到 ,获得积分10
22秒前
23秒前
23秒前
伶俐白凝发布了新的文献求助10
23秒前
奋斗小公主完成签到,获得积分10
23秒前
AaoTii完成签到,获得积分10
26秒前
zdx1022完成签到,获得积分10
26秒前
启程牛牛完成签到,获得积分10
26秒前
27秒前
fishhh完成签到,获得积分20
27秒前
zzh0409km发布了新的文献求助10
28秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 850
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3248917
求助须知:如何正确求助?哪些是违规求助? 2892299
关于积分的说明 8270565
捐赠科研通 2560582
什么是DOI,文献DOI怎么找? 1389114
科研通“疑难数据库(出版商)”最低求助积分说明 651004
邀请新用户注册赠送积分活动 627855